Effects of Low and High Doses of Atorvastatin on Arterial Compliance (original) (raw)
The Effect of Atorvastatin Intensity, Obesity, Gender, and
Mustafa Y . G . Younis
View PDFchevron_right
Atorvastatin treatment meets new European recommendations for the treatment of dyslipidemias
jana golob
Cardiologia Croatica, 2012
View PDFchevron_right
Atorvastatin Pleiotropism: Role in Cardioprotection
Gurfateh Singh
International Journal of Pharmaceutical & Biological …, 2011
View PDFchevron_right
Adiponectin plasma levels are increased by atorvastatin treatment in subjects at high cardiovascular risk
Jesus Egido
European Journal of Pharmacology, 2008
View PDFchevron_right
To compare the efficacy of alternate day versus everyday dosing of atorvastatin in hyperlipidemic rabbits
Sarita Mulkalwar
International Journal of Basic and Clinical Pharmacology, 2016
View PDFchevron_right
Effects of atorvastatin on higher functions
GURUNATH Parale
European Journal of Clinical Pharmacology, 2006
View PDFchevron_right
Atherosclerosis
Adel Allam
Global Heart, 2014
View PDFchevron_right
Efficacy of Atorvastatin Reload in Patients on Chronic Statin Therapy Undergoing Percutaneous Coronary Intervention
Vincenzo Pasceri
Journal of the American College of Cardiology, 2009
View PDFchevron_right
Impact of an integrated intervention program on atorvastatin adherence: a randomized controlled trial
Mitch Dekoven
International Journal of General Medicine, 2013
View PDFchevron_right
Identify and Assess Drug Interactions with Atorvastatin in Inpatient Care
Kingsley E Adukpoh
2021
View PDFchevron_right
Efficacy and safety of rosuvastatin and atorvastatin in patients with hypercholesterolemia and a high risk of coronary heart disease: a randomized, controlled trial
Ali Raza
American Heart Journal, 2004
View PDFchevron_right
Randomized Dose-Response Study of Rosuvastatin in Japanese Patients With Hypercholesterolemia
ALI RAZA
Journal of Atherosclerosis and Thrombosis, 2003
View PDFchevron_right
Comparison of Efficacy and Safety of Rosuvastatin Versus Atorvastatin in African-American Patients in a Six-Week Trial
Bilal Zu'by
The American Journal of Cardiology, 2006
View PDFchevron_right
Statins: effects beyond cholesterol lowering
Garry Shen
Nephrology Dialysis Transplantation, 2001
View PDFchevron_right
Hypertension and Atrial Fibrillation
Simone Bianchi
Critical Pathways in Cardiology, 2014
View PDFchevron_right
An overview of pleiotropic effect of statins in cardiovascular disease
Kumud Upadhyaya
Pharmacy & pharmacology international journal, 2018
View PDFchevron_right
Atherosclerosis and Physical Activity
Ali Al-mamari
Oman Medical Journal, 2009
View PDFchevron_right
The THRombolysis and STatins (THRaST) study
Maurizio MelIs
Neurology, 2013
View PDFchevron_right
Effect of Pravastatin and Atorvastatin on Glucose Metabolism in NonDiabetic Patients with Hypercholesterolemia
Masao Moroi
Internal Medicine, 2006
View PDFchevron_right
Differential metabolic effects of rosuvastatin and pravastatin in hypercholesterolemic patients
Michael J Quon
International Journal of Cardiology, 2013
View PDFchevron_right
A six-month, multicenter, open-label, noncomparative, prospective, observational study of the efficacy and tolerability of atorvastatin in the primary care setting(estudio del control de las hiperlipidemiasen atención primaria): the cheap study
Javier Martinez
Current Therapeutic Research, 2003
View PDFchevron_right
Early vascular and metabolic effects of rosuvastatin compared with simvastatin in patients with type 2 diabetes
Marco Lombardo
Atherosclerosis, 2010
View PDFchevron_right
Atorvastatin and persistent atrial fibrillation following cardioversion: a randomized placebo-controlled multicentre study
Steen Jensen
European Heart Journal, 2008
View PDFchevron_right
Atorvastatin improves cardiac function and remodeling in chronic non-ischemic heart failure: A clinical and pre-clinical study
Adel Omar
The Egyptian Heart Journal, 2015
View PDFchevron_right
Faculty of 1000 evaluation for Angiotensin II causes hypertension and cardiac hypertrophy through its receptors in the kidney
Søren Sheikh
F1000 - Post-publication peer review of the biomedical literature, 2006
View PDFchevron_right
Arterial compliance in obese young subjects
Guido Grassi
Journal of Hypertension, 1993
View PDFchevron_right
Comparison of Atorvastatin and Simvastatin in Prevention of Atrial Fibrillation After Successful Cardioversion
Qiang Yao
International Heart Journal, 2009
View PDFchevron_right
Expanded Clinical Evaluation of Lovastatin (EXCEL) study results. Effect of patient characteristics on lovastatin-induced changes in plasma concentrations of lipids and lipoproteins
Sandra Stinnett
Circulation, 1992
View PDFchevron_right
Rosuvastatin in Older Patients with Systolic Heart Failure
John Kjekshus
New England Journal of Medicine, 2007
View PDFchevron_right
Cardiac Titin and Heart Disease
Henk Granzier
Journal of Cardiovascular Pharmacology, 2014
View PDFchevron_right
Metabolic syndrome and pulse pressure
G. Pepe
Diabetes, Obesity and Metabolism, 2007
View PDFchevron_right
Vascular Complications in Human Disease
Michael Dashwood
2008
View PDFchevron_right
Therapeutical Approach of Arterial Hypertension
Genel Sur
Pharmaceutica Analytica Acta, 2011
View PDFchevron_right
Capítulo 4 - Estratificaçã o de Risco Cardiovascular
Vera Koch
Arquivos Brasileiros de Cardiologia, 2016
View PDFchevron_right
Comparative evaluation of the effect of statin drugs in Hyperlipidaemic patients
JAWAHAR FAROOK
2011
View PDFchevron_right